Body Handbook კატალოგი პროფილი რეიტინგი
მხედველობა BODY HANDBOOK
მხედველობა · §28
Amsler Grid
A square of black lines with a dot in the middle. Cover one eye, stare at the dot, and check whether lines look wavy, gray, or missing. It catches the bleeding form of macular degeneration in the days that decide whether you keep central vision. Here's what you didn't know you didn't know: it isn't a screen. It earns daily use only for an at-risk few; everyone else it mostly sends false alarms. For the right person, it buys the days that save the eye.
Screen · ყოველდღე მტკიცებულება განვითარებადი თავი მხედველობა

Lines look bent because the retina is being pushed out of shape. Wet AMD leaks a dome of fluid under the center of the retina. The brain still reads the lifted photoreceptors as flat, so a grid line crossing the dome looks wavy 1. The grid sees only the central 20 degrees; anything further out it cannot detect.

It's a mediocre test that's defensible only because it's free. In dry AMD eyes it catches about seven in ten wet conversions and false-alarms on roughly a third of stable days 2. Its edge is available daily between clinic visits, when the alternative is no monitoring at all.

Three groups should do this daily. Almost nobody else should. One eye already treated for wet AMD, watching the other, where conversion runs near 10% a year 3. Intermediate dry AMD an eye doctor has already seen, with roughly 18% turning wet over five years 4. Or a parent or sibling with AMD when you're past 60. Outside those, false alarms outnumber real catches.

New waves, gray patches, or a missing corner means a same-day call. Wet lesions grow over days, and the vision you keep is set by the lesion size when treatment starts 5. No slot within 48 hours means an emergency eye clinic.

The part that vanishes is the face across the table. Untreated wet AMD turns a bent line into a gray smudge into a permanent dark hole in central vision, over weeks. Injections stop the damage but can't rebuild dead photoreceptors 5. It is the leading cause of irreversible blindness over 60 6.

ForeseeHome, a tabletop hyperacuity device, catches more and is Medicare-covered for high-risk dry AMD. The real upgrade is shorter clinic intervals with an OCT scan, which sees fluid before you see a wavy line; the grid just tells you when to ask for one off-schedule 7.

The fine print — when to skip it, and what people get wrong

Both eyes open is worthless: the good eye fills in for the bad, so cover one. A clean grid isn't a clean retina; it can't see small blind spots the brain paints over 1.

It's not a screen: a healthy adult collects false positives from migraine aura, dry eye, or a tired evening. And "the grid was fine" is no reason to skip the dilated exam 7.

References
  1. 1Tripathy K, Salini B (2023). Amsler Grid. link
  2. 2Bjerager J, Schneider M, Potapenko I, et al. (2023). Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. JAMA Ophthalmology. link
  3. 3AREDS2-HOME Study Research Group; Chew EY, Clemons TE, Bressler SB, et al. (2014). Randomized trial of a home monitoring system for early detection of choroidal neovascularization: home monitoring of the Eye (HOME) study. Ophthalmology. link
  4. 4Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology. link
  5. 5Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Maguire MG, Martin DF, et al. (2016). Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. link
  6. 6Wong WL, Su X, Li X, et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. link
  7. 7Flaxel CJ, Adelman RA, Bailey ST, et al. (2020). Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. link
·
28